Teladoc Health (NYSE:TDOC) Reaches New 52-Week Low – Here’s What Happened

Teladoc Health, Inc. (NYSE:TDOC) reached a new 52-week low during trading on Friday . The stock traded as low as $6.76 and last traded at $7.15, with a volume of 3009987 shares. The stock had previously closed at $7.53.

Wall Street Analyst Weigh In

A number of research firms have weighed in on TDOC. Royal Bank of Canada raised their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Piper Sandler dropped their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Oppenheimer cut their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Finally, Bank of America increased their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a report on Wednesday, February 12th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $11.26.

Teladoc Health Price Performance

The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a fifty day moving average price of $10.14 and a 200 day moving average price of $9.77. The company has a market capitalization of $1.26 billion, a P/E ratio of -1.26 and a beta of 1.73.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. On average, sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company’s stock, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.95% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC raised its position in shares of Teladoc Health by 22.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider’s stock worth $134,000 after buying an additional 2,662 shares in the last quarter. PKO Investment Management Joint Stock Co bought a new position in Teladoc Health during the 4th quarter valued at $227,000. Brucke Financial Inc. bought a new position in Teladoc Health during the 4th quarter valued at $92,000. Vise Technologies Inc. raised its stake in shares of Teladoc Health by 4.9% in the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock worth $274,000 after buying an additional 1,405 shares in the last quarter. Finally, PharVision Advisers LLC acquired a new stake in shares of Teladoc Health in the fourth quarter valued at $301,000. 76.82% of the stock is currently owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.